264 related articles for article (PubMed ID: 24631728)
1. Synthesis and anticancer structure activity relationship investigation of cationic anthraquinone analogs.
Shrestha JP; Fosso MY; Bearss J; Chang CW
Eur J Med Chem; 2014 Apr; 77():96-102. PubMed ID: 24631728
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel bis-anthraquinone derivatives and their biological evaluation as antitumor agents.
Taher AT; Hegazy GH
Arch Pharm Res; 2013 May; 36(5):573-8. PubMed ID: 23471561
[TBL] [Abstract][Full Text] [Related]
3. Annulation of substituted anthracene-9,10-diones yields promising selectively antiproliferative compounds.
Castro-Castillo V; Suárez-Rozas C; Castro-Loiza N; Theoduloz C; Cassels BK
Eur J Med Chem; 2013 Apr; 62():688-92. PubMed ID: 23454511
[TBL] [Abstract][Full Text] [Related]
4. Safe and easy route for the synthesis of 1,3-dimethyl-1,2,3-triazolium salt and investigation of its anticancer activities.
Shrestha JP; Chang CW
Bioorg Med Chem Lett; 2013 Nov; 23(21):5909-11. PubMed ID: 24035093
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiproliferative activity of 1,4-bis(dimethylamino)-9,10-anthraquinone derivatives against P388 mouse leukemic tumor cells.
Jin GZ; Jin HS; Jin LL
Arch Pharm Res; 2011 Jul; 34(7):1071-6. PubMed ID: 21811913
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, DNA binding, and cytotoxicity studies of pyrrolo[2,1-c][1,4]benzodiazepine-anthraquinone conjugates.
Kamal A; Ramu R; Tekumalla V; Khanna GB; Barkume MS; Juvekar AS; Zingde SM
Bioorg Med Chem; 2007 Nov; 15(22):6868-75. PubMed ID: 17822905
[TBL] [Abstract][Full Text] [Related]
7. Library synthesis and antibacterial investigation of cationic anthraquinone analogs.
Fosso MY; Chan KY; Gregory R; Chang CW
ACS Comb Sci; 2012 Mar; 14(3):231-5. PubMed ID: 22324350
[TBL] [Abstract][Full Text] [Related]
8. Design and Syntheses of Novel Fluoroporphyrin-Anthraquinone Complexes as Antitumor Agents.
Yang GL; Zhao SF; Chen NY; Li S
Chem Pharm Bull (Tokyo); 2016; 64(9):1310-4. PubMed ID: 27581635
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization and in vitro anticancer evaluation of novel 1,2,4-triazolin-3-one derivatives.
Kattimani PP; Kamble RR; Kariduraganavar MY; Dorababu A; Hunnur RK
Eur J Med Chem; 2013 Apr; 62():232-40. PubMed ID: 23353755
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antibacterial activity study of a novel class of cationic anthraquinone analogs.
Zhang J; Redman N; Litke AP; Zeng J; Zhan J; Chan KY; Chang CW
Bioorg Med Chem; 2011 Jan; 19(1):498-503. PubMed ID: 21111625
[TBL] [Abstract][Full Text] [Related]
11. Natural product-based design, synthesis and biological evaluation of anthra[2,1-d]thiazole-6,11-dione derivatives from rhein as novel antitumour agents.
Liang YK; Yue ZZ; Li JX; Tan C; Miao ZH; Tan WF; Yang CH
Eur J Med Chem; 2014 Sep; 84():505-15. PubMed ID: 25050882
[TBL] [Abstract][Full Text] [Related]
12. Novel rhein analogues as potential anticancer agents.
Yang X; Sun G; Yang C; Wang B
ChemMedChem; 2011 Dec; 6(12):2294-301. PubMed ID: 21954017
[TBL] [Abstract][Full Text] [Related]
13. Novel anthraquinone based chalcone analogues containing an imine fragment: synthesis, cytotoxicity and anti-angiogenic activity.
Kolundžija B; Marković V; Stanojković T; Joksović L; Matić I; Todorović N; Nikolić M; Joksović MD
Bioorg Med Chem Lett; 2014 Jan; 24(1):65-71. PubMed ID: 24332490
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, human telomerase inhibition and anti-proliferative studies of a series of 2,7-bis-substituted amido-anthraquinone derivatives.
Huang HS; Huang KF; Li CL; Huang YY; Chiang YH; Huang FC; Lin JJ
Bioorg Med Chem; 2008 Jul; 16(14):6976-86. PubMed ID: 18571928
[TBL] [Abstract][Full Text] [Related]
15. Anthraquinone derivatives induce G2/M cell cycle arrest and apoptosis in NTUB1 cells.
Tu HY; Huang AM; Teng CH; Hour TC; Yang SC; Pu YS; Lin CN
Bioorg Med Chem; 2011 Sep; 19(18):5670-8. PubMed ID: 21852140
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anticancer activity of novel 2-pyridyl hexahyrocyclooctathieno[2,3-d]pyrimidine derivatives.
Kassab AE; Gedawy EM
Eur J Med Chem; 2013 May; 63():224-30. PubMed ID: 23501108
[TBL] [Abstract][Full Text] [Related]
17. Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties.
Tikhomirov AS; Litvinova VA; Andreeva DV; Tsvetkov VB; Dezhenkova LG; Volodina YL; Kaluzhny DN; Treshalin ID; Schols D; Ramonova AA; Moisenovich MM; Shtil AA; Shchekotikhin AE
Eur J Med Chem; 2020 Aug; 199():112294. PubMed ID: 32428792
[TBL] [Abstract][Full Text] [Related]
18. Ring fusion strategy for synthesis and lead optimization of sulfur-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-dione derivatives as promising scaffold of antitumor agents.
Lee YR; Chen TC; Lee CC; Chen CL; Ahmed Ali AA; Tikhomirov A; Guh JH; Yu DS; Huang HS
Eur J Med Chem; 2015 Sep; 102():661-76. PubMed ID: 26344783
[TBL] [Abstract][Full Text] [Related]
19. 1,4,9,10-Anthradiquinone as precursor for antitumor compounds.
Schenck LW; Kuna K; Frank W; Albert A; Asche C; Kucklaender U
Bioorg Med Chem; 2006 May; 14(10):3599-614. PubMed ID: 16458517
[TBL] [Abstract][Full Text] [Related]
20. Anthracene-9, 10-dione derivatives induced apoptosis in human cervical cancer cell line (CaSki) by interfering with HPV E6 expression.
Sangthong S; Sangphech N; Palaga T; Ngamrojanavanich N; Puthong S; Vilaivan T; Muangsin N
Eur J Med Chem; 2014 Apr; 77():334-42. PubMed ID: 24657570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
